Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians

Código QR

Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians

Guardado en:

Detalles Bibliográficos
Autores principales:	Suneet Mittal, David Golombeck, Jacqueline Pimienta
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/c5fab154f84e444f83e81b3b5ef2df50
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Relationship Between Obstructive Sleep Apnoea and AF
por: Ghanshyam Shantha, et al.
Publicado: (2019)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method
por: Ali Çoner
Publicado: (2021)

New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method
por: Mustafa Arıcı, et al.
Publicado: (2021)

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
por: Lucas C Godoy, et al.
Publicado: (2019)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: María Pilar Resano-Barrio, et al.
Publicado: (2020)

Rhythm Control in AF: Have We Reached the Last Frontier?
por: Gheorghe-Andrei Dan
Publicado: (2019)

Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
por: K Pukite, et al.
Publicado: (2020)

Human Immunodeficiency Virus disease and cardiac surgery – where are we?
por: David Blyth
Publicado: (2017)

Where do we stand?
por: Ocampo, José Antonio
Publicado: (2014)

Diabetes Care in Iran: Where We Stand and Where We Are Headed
por: Sina Noshad, et al.
Publicado: (2016)

Challenges Associated with Interpreting Mechanisms of AF
por: Caroline H Roney, et al.
Publicado: (2020)

Mapping and Imaging in Non-paroxysmal AF
por: Michael Ghannam, et al.
Publicado: (2019)

High-resolution Mapping in Patients with Persistent AF
por: Marius Andronache, et al.
Publicado: (2019)

Atrial Fibrosis: Translational Considerations for the Management of AF Patients
por: Stylianos Tzeis, et al.
Publicado: (2019)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Ana Pardo Sanz, et al.
Publicado: (2019)

Understanding AF Mechanisms Through Computational Modelling and Simulations
por: Konstantinos N Aronis, et al.
Publicado: (2019)

Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
por: Iskren Garvanski, et al.
Publicado: (2019)

Ivabradine and AF: Coincidence, Correlation or a New Treatment?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF
por: Sandeep Prabhu, et al.
Publicado: (2019)

High-power, Short-duration Radiofrequency Ablation for the Treatment of AF
por: Irum D Kotadia, et al.
Publicado: (2020)

What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?
por: Islam Y Elgendy, et al.
Publicado: (2020)

Individualised Approaches for Catheter Ablation of AF: Patient Selection and Procedural Endpoints
por: Nicolas Johner, et al.
Publicado: (2019)

Canine Babesiosis: Where Do We Stand?
por: Petra Bilić, et al.
Publicado: (2018)

Industrial policy: where do we stand?
por: Peres Núñez, Wilson
Publicado: (2014)

Obstructive Sleep Apnoea in Stanford Type B Aortic Dissection Is Associated With Multiple Imaging Signs Related to Late Aortic Events
por: Jiawei Zhang, et al.
Publicado: (2021)

Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
por: Allegra Battistoni, et al.
Publicado: (2020)

Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure
por: Michela Faggioni, et al.
Publicado: (2020)

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021)

Hybrid Convergent Procedure for the Treatment of Persistent and Long-standing Persistent Atrial Fibrillation
por: David B DeLurgio, et al.
Publicado: (2021)

Anticoagulation in Peripheral Artery Disease: Are We There Yet?
por: Alessandro Cannavale, et al.
Publicado: (2020)

Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)

Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
por: Li-Feng Hu, et al.
Publicado: (2021)

DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
por: Waail Rozi, et al.
Publicado: (2021)

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Yutao Guo, et al.
Publicado: (2020)

Diabetes and mortality in patients with COVID-19: Are we missing the link?
por: Marco Toselli2, et al.
Publicado: (2021)

Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?
por: Roberto Scarsini, et al.
Publicado: (2020)

Thrombosis in COVID-19: We still need to learn a lot
por: Cem Barçın
Publicado: (2021)

Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?
por: Paulbuddhe V, et al.
Publicado: (2021)